Ximelagatran Compared with Warfarin for the Prevention of Systemic Embolism and Stroke. An Imputed Placebo Analysis
- 1 March 2005
- journal article
- research article
- Published by Springer Nature in Cardiovascular Drugs and Therapy
- Vol. 19 (2) , 149-151
- https://doi.org/10.1007/s10557-005-3405-4
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Ximelagatran or Warfarin for Stroke Prevention in Patients With Atrial Fibrillation?Stroke, 2004
- Stroke prevention with the oral direct thrombin inhibitor ximelagatran compared with warfarin in patients with non-valvular atrial fibrillation (SPORTIF III): randomised controlled trialThe Lancet, 2003
- Can we pull the plug on warfarin in atrial fibrillation?The Lancet, 2003
- A population-based study of the long-term risks associated with atrial fibrillation: 20-year follow-up of the Renfrew/Paisley studyPublished by Elsevier ,2002
- Statistical Methods for Comparison to Placebo in Active-Control TrialsDrug Information Journal, 2001
- Risk Factors for Stroke and Efficacy of Antithrombotic Therapy in Atrial FibrillationArchives of internal medicine (1960), 1994
- Beta blockade during and after myocardial infarction: An overview of the randomized trialsProgress in Cardiovascular Diseases, 1985